Breast Cancer
Showing NaN - NaN of 209
Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)
Recruiting
- Breast Cancer
- Ipatasertib
- +2 more
-
Bowral, New South Wales, Australia
- +37 more
Aug 8, 2022
Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)
Breast Cancer Trial in Worldwide (biological, drug, other, procedure)
Active, not recruiting
- Breast Cancer
- nivolumab
- +6 more
-
Mobile, Alabama
- +255 more
Jul 21, 2022
Non-Invasive Artificial Intelligence-Based Platform MonIToring
Recruiting
- Breast Cancer
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jul 21, 2022
Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan)
Recruiting
- Breast Cancer
- Trastuzumab Deruxtecan
-
San Diego, California
- +90 more
Jul 19, 2022
Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
Breast Cancer, Heart Failure Trial in Canada, Russian Federation (Trastuzumab, Pertuzumab, Trastuzumab emtansine)
Recruiting
- Breast Cancer
- Heart Failure
- Trastuzumab
- +2 more
-
Hamitlon, Ontario, Canada
- +3 more
Jun 21, 2022
Marathon of Hope Cancer Centres Network Study for Ontario
Recruiting
- Breast Cancer
- +11 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jun 6, 2022
Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))
Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)
Active, not recruiting
- Breast Cancer
- Amcenestrant-matching placebo
- +5 more
-
Daphne, Alabama
- +299 more
May 5, 2022
Breast Cancer Trial in Toronto (SBRT)
Recruiting
- Breast Cancer
- SBRT
-
Toronto, Ontario, CanadaSunnybrook Odette Cancer Centre
May 5, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan (T-DXd)
- Ado-trastuzumab emtansine (T-DM1)
-
Los Angeles, California
- +163 more
Apr 1, 2022
Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
Recruiting
- Breast Cancer
- +10 more
-
Hamilton, Ontario, Canada
- +6 more
Apr 21, 2022
Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Palbociclib
- Standard Adjuvant Endocrine Therapy
-
Mobile, Alabama
- +437 more
Mar 21, 2022
Breast Cancer Trial in Toronto (Intervention Arm, Control Group)
Recruiting
- Breast Cancer
- Intervention Arm
- Control Group
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre, University Health Network
Apr 8, 2022
Improving Quality of Life for Breast Cancer Invading Chest Wall:
Recruiting
- Breast Cancer
- FACT-B and Brief Pain Inventory
-
Ann Arbor, Michigan
- +1 more
Apr 8, 2022
Breast Cancer, DCIS Trial in Canada (APBI: 30 Gy, APBI: 27.5 Gy)
Active, not recruiting
- Breast Cancer
- DCIS
- APBI: 30 Gy
- APBI: 27.5 Gy
-
Barrie, Ontario, Canada
- +9 more
Apr 4, 2022
Breast Cancer Trial in Worldwide (Trastuzumab Emtansine)
Completed
- Breast Cancer
- Trastuzumab Emtansine
-
Buenos Aires, Argentina
- +299 more
Mar 31, 2022
Breast Cancer, Nerve Block, Regional Anesthesia Trial in Toronto (Erector spinae plane block, Placebo Block)
Not yet recruiting
- Breast Cancer
- +3 more
- Erector spinae plane block
- Placebo Block
-
Toronto, Ontario, CanadaWomen's College Hospital
Mar 10, 2022
Breast Cancer, Breast Tumors Trial in Toronto (Exercise Counselling, Partner Matching)
Completed
- Breast Cancer
- Breast Neoplasms
- Exercise Counselling
- Partner Matching
-
Toronto, Ontario, CanadaUniversity of Toronto
Feb 25, 2022
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022